Rujukan Kyowa Kirin

  1. ↑ "Kyowa Hakko Kirin Company Overview". Kyowa Hakko Kirin. Dicapai pada March 14, 2014.
  2. ↑ "Kyowa Hakko Kirin Corporate Profile" (PDF). Kyowa Hakko Kirin. Dicapai pada March 14, 2014.
  3. ↑ "Kyowa Hakko Kirin Annual Report 2012". Kyowa Hakko Kirin. Dicapai pada March 14, 2014.
  4. ↑ "Components:Nikkei Stock Average". Nikkei Inc. Dicapai pada January 20, 2015.
  5. ↑ "Top 50 Pharma Companies by 2012 Revenue". Wildwood Ventures Ltd. Dicapai pada March 14, 2014.
  6. ↑ "ProStrakan Acquires Archimedes Pharma for $394M". Genetic Engineering & Biotechnology News. Mary Ann Liebert, Inc. July 11, 2014. Dicapai pada January 20, 2015.
  7. ↑ Yu, X; Marshall, MJE; Cragg, MS; Crispin, M (June 2017). "Improving Antibody-Based Cancer Therapeutics Through Glycan Engineering" (PDF). BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy. 31 (3): 151–166. doi:10.1007/s40259-017-0223-8. PMID 28466278.
  8. ↑ "FY 2013 Consolidated Financial Summary". Kyowa Hakko Kirin. Dicapai pada March 14, 2014.

Rujukan

WikiPedia: Kyowa Kirin http://www.currentpartnering.com/insight/top-50-ph... http://asia.cdn.euroland.com/arinhtml/JP-KY4/2012/... http://www.genengnews.com/gen-news-highlights/khk-... http://www.kyowa-kirin.com/about_us/overview/index... http://www.kyowa-kirin.com/about_us/overview/pdf/c... http://www.kyowa-kirin.com/index.html http://www.boerse-frankfurt.de/en/equities/search/... //pubmed.ncbi.nlm.nih.gov/28466278 http://www.kyowa-kirin.co.jp/english/index.html http://indexes.nikkei.co.jp/en/nkave/index/compone...